当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析 - 现金流量表

回盛生物

(300871)

  

流通市值:44.45亿  总市值:44.45亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金946,899,543.93639,310,182.87326,279,066.99993,405,077.95
  收到的税费返还8,262,739.38,262,739.3-2,870,091.87
  收到其他与经营活动有关的现金36,422,655.317,770,597.135,976,185.1530,767,615.96
  经营活动现金流入小计991,584,938.53665,343,519.3332,255,252.141,027,042,785.78
  购买商品、接受劳务支付的现金574,022,892.15393,921,808.8202,385,667.68716,596,742.24
  支付给职工以及为职工支付的现金110,923,067.2975,869,225.342,278,375.73136,269,452.92
  支付的各项税费55,831,743.930,343,922.0510,861,356.9243,135,292.86
  支付其他与经营活动有关的现金69,292,174.4441,355,837.5618,769,587.6587,509,450.95
  经营活动现金流出小计810,069,877.78541,490,793.71274,294,987.98983,510,938.97
  经营活动产生的现金流量净额181,515,060.75123,852,725.5957,960,264.1643,531,846.81
二、投资活动产生的现金流量:
  收回投资收到的现金489,274,905.64273,934,405.6495,116,974.52660,289,533.07
  取得投资收益收到的现金5,040,367.333,637,846.49667,432.58,185,734.79
  处置固定资产、无形资产和其他长期资产收回的现金净额380,000380,000380,000422,636.08
  投资活动现金流入小计494,695,272.97277,952,252.1396,164,407.02668,897,903.94
  购建固定资产、无形资产和其他长期资产支付的现金70,454,855.7751,722,454.4338,179,940.01194,426,199.53
  投资支付的现金568,190,500345,450,000185,450,000576,286,492.54
  取得子公司及其他营业单位支付的现金1,146,800.35---
  投资活动现金流出小计639,792,156.12397,172,454.43223,629,940.01770,712,692.07
  投资活动产生的现金流量净额-145,096,883.15-119,220,202.3-127,465,532.99-101,814,788.13
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,106,705.85--19,495,458
  其中:子公司吸收少数股东投资收到的现金3,106,705.85--3,140,958
  取得借款收到的现金190,000,000180,000,000120,000,000480,000,000
  收到其他与筹资活动有关的现金34,251,98423,658,1784,116,22056,592,014
  筹资活动现金流入小计227,358,689.85203,658,178124,116,220556,087,472
  偿还债务支付的现金246,074,853.92214,074,853.9285,000,000479,555,978.39
  分配股利、利润或偿付利息支付的现金48,388,903.1625,965,207.352,487,468.8659,155,946.52
  支付其他与筹资活动有关的现金947,600354,500272,0003,399,179.43
  筹资活动现金流出小计295,411,357.08240,394,561.2787,759,468.86542,111,104.34
  筹资活动产生的现金流量净额-68,052,667.23-36,736,383.2736,356,751.1413,976,367.66
四、汇率变动对现金及现金等价物的影响-130,204.92108,497.32404,235.28-613,772.49
五、现金及现金等价物净增加额-31,764,694.55-31,995,362.66-32,744,282.41-44,920,346.15
  加:期初现金及现金等价物余额184,591,943.24184,591,943.24184,591,943.24229,512,289.39
  期末现金及现金等价物余额152,827,248.69152,596,580.58151,847,660.83184,591,943.24
补充资料:
  净利润-117,545,832.95--19,773,164.88
  资产减值准备-2,142,279.23-660,419.44
  固定资产和投资性房地产折旧-57,390,335.2-110,255,352.79
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-57,390,335.2-110,255,352.79
  无形资产摊销-1,688,957.46-3,030,435.91
  长期待摊费用摊销-291,280.01-759,869.74
  固定资产报废损失-21,157.69-208,272.14
  公允价值变动损失--7,488,537.35-23,638,504.81
  财务费用-11,383,103.99-42,814,265.18
  投资损失--3,616,674.49--8,185,502.6
  递延所得税-2,447,778.39--19,559,762.92
  其中:递延所得税资产减少-6,099,537.92--5,515,078.67
    递延所得税负债增加--3,651,759.53--14,044,684.25
  存货的减少-1,018,015.3--20,834,632.15
  经营性应收项目的减少-14,177,420.75--210,124,792.87
  经营性应付项目的增加--70,438,111.79-136,381,609.48
  其他--2,710,111.75-4,260,972.74
  现金的期末余额-152,596,580.58-184,591,943.24
  减:现金的期初余额-184,591,943.24-229,512,289.39
  现金及现金等价物的净增加额--31,995,362.66--44,920,346.15
公告日期2025-10-282025-08-062025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑